(Q51089050)
Statements
Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis. (English)
1 reference
D C Mohr
1 reference
D E Goodkin
1 reference
L Masuoka
1 reference
L P Dick
1 reference
D Russo
1 reference
J Eckhardt
1 reference
A C Boudewyn
1 reference
L Bedell
1 reference
1 June 1999
1 reference
5
1 reference
3
1 reference
192-197
1 reference